Bhubaneswar, Oct 13 [UDN}:For this purpose, a four-party licensing agreement has been signed among IIT Bhubaneswar, the Institute of Life Sciences (ILS), the National Research Development Corporation (NRDC), and TechInvention Lifecare Limited.
The agreement is expected to strengthen collaboration in the research, development, and industrial-scale application of new vaccine technology, while opening up new possibilities for the prevention and control of tuberculosis (TB).
However, no specific timeline has been announced for the commercial production or availability of the vaccine.
Leave a Reply